SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Ji, J. Sundquist, K. Sundquist, Association of alcohol use disorders with amyotrophic lateral sclerosis: a Swedish national cohort study, European Journal of Neurology, 2016, 23, 2
  2. 2
    Zohreh Bagher, Somayeh Ebrahimi-Barough, Mahmoud Azami, Majid Safa, Mohammad Taghi Joghataei, Cellular activity of Wharton's Jelly-derived mesenchymal stem cells on electrospun fibrous and solvent-cast film scaffolds, Journal of Biomedical Materials Research Part A, 2016, 104, 1
  3. 3
    Alida Spalloni, Patrizia Longone, Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse, Neuroscience & Biobehavioral Reviews, 2016, 60, 12

    CrossRef

  4. 4
    Daniel Cacabelos, Omar Ramírez-Núñez, Ana Belén Granado-Serrano, Pascual Torres, Victòria Ayala, Victoria Moiseeva, Mònica Povedano, Isidre Ferrer, Reinald Pamplona, Manuel Portero-Otin, Jordi Boada, Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS, Acta Neuropathologica Communications, 2016, 4, 1

    CrossRef

  5. 5
    Yuan-Jin Zhang, Dong-Sheng Fan, Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression, Chinese Medical Journal, 2016, 129, 1, 28

    CrossRef

  6. 6
    Anna Gajowiak, Agnieszka Styś, Rafał R. Starzyński, Aleksandra Bednarz, Małgorzata Lenartowicz, Robert Staroń, Paweł Lipiński, Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1G93A Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis, Frontiers in Molecular Neuroscience, 2016, 8,

    CrossRef

  7. 7
    Chen Benkler, Yael Barhum, Tali Ben-Zur, Daniel Offen, Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model, Journal of Molecular Neuroscience, 2016, 58, 1, 46

    CrossRef

  8. 8
    Simran J. Kaur, Stephanie R. McKeown, Shazia Rashid, Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis, Gene, 2016, 577, 2, 109

    CrossRef

  9. 9
    Elizabeth A. Proctor, Lanette Fee, Yazhong Tao, Rachel L. Redler, James M. Fay, Yuliang Zhang, Zhengjian Lv, Ian P. Mercer, Mohanish Deshmukh, Yuri L. Lyubchenko, Nikolay V. Dokholyan, Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis, Proceedings of the National Academy of Sciences, 2016, 113, 3, 614

    CrossRef

  10. 10
    Emma R. Perri, Colleen J. Thomas, Sonam Parakh, Damian M. Spencer, Julie D. Atkin, The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration, Frontiers in Cell and Developmental Biology, 2016, 3,

    CrossRef

  11. 11
    Tamar Getter, Ilana Zaks, Yael Barhum, Tali Ben-Zur, Sebastian Böselt, Simpson Gregoire, Olga Viskind, Tom Shani, Hugo Gottlieb, Omer Green, Moran Shubely, Hanoch Senderowitz, Adrian Israelson, Inchan Kwon, Susanne Petri, Daniel Offen, Arie Gruzman, A Chemical Chaperone-Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS), ChemMedChem, 2015, 10, 5
  12. 12
    Abigail DeLoach, Michael Cozart, Arianna Kiaei, Mahmoud Kiaei, A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies, Expert Opinion on Drug Discovery, 2015, 10, 10, 1099

    CrossRef

  13. 13
    Christine V. Fontanilla, Huiying Gu, Qingpeng Liu, Timothy Z. Zhu, Changwei Zhou, Brian H. Johnstone, Keith L. March, Robert M. Pascuzzi, Martin R. Farlow, Yansheng Du, Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis, Scientific Reports, 2015, 5, 16953

    CrossRef

  14. 14
    S.T. Ngo, F.J. Steyn, L. Huang, S. Mantovani, C.M.M. Pfluger, T.M. Woodruff, J.D. O'Sullivan, R.D. Henderson, P.A. McCombe, Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis, Journal of the Neurological Sciences, 2015, 357, 1-2, 22

    CrossRef

  15. 15
    Raffaele Nardone, Yvonne Höller, Alexandra C. Taylor, Piergiorgio Lochner, Frediano Tezzon, Stefan Golaszewski, Francesco Brigo, Eugen Trinka, Canine degenerative myelopathy: a model of human amyotrophic lateral sclerosis, Zoology, 2015,

    CrossRef

  16. 16
    Joseph M Scarrott, Saúl Herranz-Martín, Aziza R Alrafiah, Pamela J Shaw, Mimoun Azzouz, Current developments in gene therapy for amyotrophic lateral sclerosis, Expert Opinion on Biological Therapy, 2015, 15, 7, 935

    CrossRef

  17. 17
    Je-Young Shin, Kwang-Woo Lee, Diagnosis and management of amyotrophic lateral sclerosis, Journal of the Korean Medical Association, 2015, 58, 2, 131

    CrossRef

  18. 18
    Betul Karademir, Ceyda Corek, Nesrin Kartal Ozer, Endoplasmic reticulum stress and proteasomal system in amyotrophic lateral sclerosis, Free Radical Biology and Medicine, 2015, 88, 42

    CrossRef

  19. 19
    L. Galán Dávila, P. López Ruiz, J. Matías-Guiu Guía, Enfermedades de las motoneuronas, Medicine - Programa de Formación Médica Continuada Acreditado, 2015, 11, 78, 4678

    CrossRef

  20. 20
    Moustapha Cissé, Frédéric Checler, Eph receptors: New players in Alzheimer's disease pathogenesis, Neurobiology of Disease, 2015, 73, 137

    CrossRef

  21. 21
    Alessandro Davoli, Viviana Greco, Alida Spalloni, Ezia Guatteo, Cristina Neri, Giada Ricciardo Rizzo, Alberto Cordella, Andrea Romigi, Claudio Cortese, Sergio Bernardini, Paola Sarchielli, Gabriela Cardaioli, Paolo Calabresi, Nicola B. Mercuri, Andrea Urbani, Patrizia Longone, Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis, Annals of Neurology, 2015, 77, 4
  22. 22
    Chrystian J. Alves, Rafael Dariolli, Frederico M. Jorge, Matheus R. Monteiro, Jessica R. Maximino, Roberto S. Martins, Bryan E. Strauss, José E. Krieger, Dagoberto Callegaro, Gerson Chadi, Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration, Frontiers in Cellular Neuroscience, 2015, 9,

    CrossRef

  23. 23
    Kou Takahashi, Joshua B. Foster, Chien-Liang Glenn Lin, Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease, Cellular and Molecular Life Sciences, 2015, 72, 18, 3489

    CrossRef

  24. 24
    Ana Rita Vaz, Carolina Cunha, Cátia Gomes, Nadja Schmucki, Marta Barbosa, Dora Brites, Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration, Molecular Neurobiology, 2015, 51, 3, 864

    CrossRef

  25. 25
    Nicole Wächter, Alexander Storch, Andreas Hermann, Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2015, 16, 7-8, 431

    CrossRef

  26. 26
    Jared Ehrhart, Adam J. Smith, Nicole Kuzmin-Nichols, Theresa A. Zesiewicz, Israt Jahan, R. Douglas Shytle, Seol-Hee Kim, Cyndy D. Sanberg, Tuan H. Vu, Clifton L. Gooch, Paul R. Sanberg, Svitlana Garbuzova-Davis, Humoral factors in ALS patients during disease progression, Journal of Neuroinflammation, 2015, 12, 1

    CrossRef

  27. 27
    Saif Khan, Khurshid Ahmad, Eyad M. A. Alshammari, Mohd Adnan, Mohd Hassan Baig, Mohtashim Lohani, Pallavi Somvanshi, Shafiul Haque, Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds, BioMed Research International, 2015, 2015, 1

    CrossRef

  28. 28
    Jose Enrique Yuste, Ernesto Tarragon, Carmen María Campuzano, Francisco Ros-Bernal, Implications of glial nitric oxide in neurodegenerative diseases, Frontiers in Cellular Neuroscience, 2015, 9,

    CrossRef

  29. 29
    Rosemary Clark, Catherine Blizzard, Tracey Dickson, Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities, Neurodegenerative Disease Management, 2015, 5, 6, 511

    CrossRef

  30. 30
    Eleonora Aronica, Frank Baas, Anand Iyer, Anneloor L.M.A. ten Asbroek, Giovanna Morello, Sebastiano Cavallaro, Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex, Neurobiology of Disease, 2015, 74, 359

    CrossRef

  31. 31
    Angela M. Brennan-Minnella, Seok Joon Won, Raymond A. Swanson, NADPH Oxidase-2: Linking Glucose, Acidosis, and Excitotoxicity in Stroke, Antioxidants & Redox Signaling, 2015, 22, 2, 161

    CrossRef

  32. 32
    Esther Verstraete, Bradley R. Foerster, Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis, Neurotherapeutics, 2015, 12, 2, 403

    CrossRef

  33. 33
    D. Jantas, A. Greda, M. Leskiewicz, B. Grygier, A. Pilc, W. Lason, Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation, Neurochemistry International, 2015, 88, 124

    CrossRef

  34. 34
    Ganna Shevchenko, Anne Konzer, Sravani Musunuri, Jonas Bergquist, Neuroproteomics tools in clinical practice, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2015, 1854, 7, 705

    CrossRef

  35. 35
    Cheryl Yung, Di Sha, Lian Li, Lih-Shen Chin, Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance, Molecular Neurobiology, 2015,

    CrossRef

  36. 36
    Morenci M. Manning, Marie Kelly-Worden, Potential Regulators of Sporadic ALS Development and Alternative Therapeutic Options, Neuroscience & Medicine, 2015, 06, 01, 5

    CrossRef

  37. 37
    A. Joardar, J. Menzl, T. C. Podolsky, E. Manzo, P. S. Estes, S. Ashford, D. C. Zarnescu, PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43, Human Molecular Genetics, 2015, 24, 6, 1741

    CrossRef

  38. 38
    Elisabeth Dirren, Julianne Aebischer, Cylia Rochat, Christopher Towne, Bernard L. Schneider, Patrick Aebischer, SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice, Annals of Clinical and Translational Neurology, 2015, 2, 2
  39. 39
    Keng Ioi Vong, Crystal Kit Ying Leung, Richard R Behringer, Kin Ming Kwan, Sox9 is critical for suppression of neurogenesis but not initiation of gliogenesis in the cerebellum, Molecular Brain, 2015, 8, 1

    CrossRef

  40. 40
    Yinan Zhang, Kevin Tianmeng Zhao, Susan G. Fox, Jinho Kim, Donald R. Kirsch, Robert J. Ferrante, Richard I. Morimoto, Richard B. Silverman, Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis, Journal of Medicinal Chemistry, 2015, 58, 15, 5942

    CrossRef

  41. 41
    Giovanna Morello, Sebastiano Cavallaro, Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy, Future Medicinal Chemistry, 2015, 7, 10, 1335

    CrossRef

  42. 42
    Harald Sontheimer, Diseases of the Nervous System, 2015,

    CrossRef

  43. 43
    Paul H. Gordon, Kate Dalton, Philippe Corcia, Diet and Nutrition in Dementia and Cognitive Decline, 2015,

    CrossRef

  44. 44
    Shyuan T. Ngo, Frederik J. Steyn, Pamela A. McCombe, Karin Borges, Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease, 2015,

    CrossRef

  45. 45
    Kristin Elf, Ganna Shevchenko, Ingela Nygren, Lars Larsson, Jonas Bergquist, Håkan Askmark, Konstantin Artemenko, Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis, Journal of Proteomics, 2014, 108, 55

    CrossRef

  46. 46
    Fuqing Zhou, Renshi Xu, Emily Dowd, Yufeng Zang, Honghan Gong, Ze Wang, Alterations in regional functional coherence within the sensory-motor network in amyotrophic lateral sclerosis, Neuroscience Letters, 2014, 558, 192

    CrossRef

  47. 47
    L. Wang, B. Popko, R. P. Roos, An enhanced integrated stress response ameliorates mutant SOD1-induced ALS, Human Molecular Genetics, 2014, 23, 10, 2629

    CrossRef

  48. 48
    Shweta Thakur, Bibekananda Sarkar, Ravi P Cholia, Nandini Gautam, Monisha Dhiman, Anil K Mantha, APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions, Experimental & Molecular Medicine, 2014, 46, 7, e106

    CrossRef

  49. 49
    R. Seijffers, J. Zhang, J. C. Matthews, A. Chen, E. Tamrazian, O. Babaniyi, M. Selig, M. Hynynen, C. J. Woolf, R. H. Brown, ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation, Proceedings of the National Academy of Sciences, 2014, 111, 4, 1622

    CrossRef

  50. 50
    R. Zeng, J.R. Coates, G.C. Johnson, L. Hansen, T. Awano, A. Kolicheski, E. Ivansson, M. Perloski, K. Lindblad-Toh, D.P. O'Brien, J. Guo, M.L. Katz, G.S. Johnson, Breed Distribution of SOD1 Alleles Previously Associated with Canine Degenerative Myelopathy, Journal of Veterinary Internal Medicine, 2014, 28, 2
  51. 51
    Frank P. Diekstra, Vivianna M. Deerlin, John C. Swieten, Ammar Al-Chalabi, Albert C. Ludolph, Jochen H. Weishaupt, Orla Hardiman, John E. Landers, Robert H. Brown, Michael A. Es, R. Jeroen Pasterkamp, Max Koppers, Peter M. Andersen, Karol Estrada, Fernando Rivadeneira, Albert Hofman, André G. Uitterlinden, Philip Damme, Judith Melki, Vincent Meininger, Aleksey Shatunov, Christopher E. Shaw, P. Nigel Leigh, Pamela J. Shaw, Karen E. Morrison, Isabella Fogh, Adriano Chiò, Bryan J. Traynor, David Czell, Markus Weber, Peter Heutink, Paul I. W. Bakker, Vincenzo Silani, Wim Robberecht, Leonard H. Berg, Jan H. Veldink, C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis, Annals of Neurology, 2014, 76, 1
  52. You have free access to this content52
    J. Simon Lunn, Stacey A. Sakowski, Eva L. Feldman, Concise Review: Stem Cell Therapies for Amyotrophic Lateral Sclerosis: Recent Advances and Prospects for the Future, STEM CELLS, 2014, 32, 5
  53. 53
    Jessica R. Maximino, Gabriela P. de Oliveira, Chrystian J. Alves, Gerson Chadi, Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  54. 54
    Tetsuya Sasaki, Tomofumi Oga, Keiko Nakagaki, Kazuhisa Sakai, Kayo Sumida, Kohei Hoshino, Izuru Miyawaki, Koichi Saito, Fumikazu Suto, Noritaka Ichinohe, Developmental genetic profiles of glutamate receptor system, neuromodulator system, protector of normal tissue and mitochondria, and reelin in marmoset cortex: Potential molecular mechanisms of pruning phase of spines in primate synaptic formation process during the end of infancy and prepuberty (II), Biochemical and Biophysical Research Communications, 2014, 444, 3, 307

    CrossRef

  55. 55
    Robert P. Lisak, Liljana Nedelkoska, Joyce A. Benjamins, Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules, Glia, 2014, 62, 5
  56. 56
    S. Mantovani, R. Gordon, J.K. Macmaw, C.M.M. Pfluger, R.D. Henderson, P.G. Noakes, P.A. McCombe, T.M. Woodruff, Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood, Journal of Neuroimmunology, 2014, 276, 1-2, 213

    CrossRef

  57. 57
    T. Prell, J. Lautenschläger, L. Weidemann, J. Ruhmer, O.W. Witte, J. Grosskreutz, Endoplasmic reticulum stress is accompanied by activation of NF-κB in amyotrophic lateral sclerosis, Journal of Neuroimmunology, 2014, 270, 1-2, 29

    CrossRef

  58. 58
    M. A. Lim, K. K. Bence, I. Sandesara, P. Andreux, J. Auwerx, J. Ishibashi, P. Seale, R. G. Kalb, Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis, Human Molecular Genetics, 2014, 23, 18, 4995

    CrossRef

  59. 59
    Weinan Sun, Denis Shchepakin, Leonid V. Kalachev, Michael P. Kavanaugh, Glutamate transporter control of ambient glutamate levels, Neurochemistry International, 2014, 73, 146

    CrossRef

  60. 60
    Wint Nandar, Elizabeth B. Neely, Zachary Simmons, James R. Connor, H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 12, 2413

    CrossRef

  61. 61
    Marta Łukaszewicz-Zając, Barbara Mroczko, Agnieszka Słowik, Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS), Journal of Neural Transmission, 2014, 121, 11, 1387

    CrossRef

  62. 62
    Dora Brites, Ana R. Vaz, Microglia centered pathogenesis in ALS: insights in cell interconnectivity, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  63. 63
    Sheila K. Pirooznia, Valina L. Dawson, Ted M. Dawson, Motor Neuron Death in ALS: Programmed by Astrocytes?, Neuron, 2014, 81, 5, 961

    CrossRef

  64. 64
    Jing Xu, Michelle H. Lacoske, Emmanuel A. Theodorakis, Neurotrophe Naturstoffe – ihre Chemie und Biologie, Angewandte Chemie, 2014, 126, 4
  65. 65
    Jing Xu, Michelle H. Lacoske, Emmanuel A. Theodorakis, Neurotrophic Natural Products: Chemistry and Biology, Angewandte Chemie International Edition, 2014, 53, 4
  66. 66
    Paul C. Trippier, Kevin Tianmeng Zhao, Susan G. Fox, Isaac T. Schiefer, Radhia Benmohamed, Jason Moran, Donald R. Kirsch, Richard I. Morimoto, Richard B. Silverman, Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis, ACS Chemical Neuroscience, 2014, 5, 9, 823

    CrossRef

  67. 67
    Joshua E. Burda, Michael V. Sofroniew, Reactive Gliosis and the Multicellular Response to CNS Damage and Disease, Neuron, 2014, 81, 2, 229

    CrossRef

  68. 68
    Jiuquan Zhang, Xuntao Yin, Lu Zhao, Alan C. Evans, Lingheng Song, Bing Xie, Haitao Li, Chunxia Luo, Jian Wang, Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis, Journal of Neurology, 2014, 261, 2, 412

    CrossRef

  69. 69
    Christof Grewer, Armanda Gameiro, Thomas Rauen, SLC1 glutamate transporters, Pflügers Archiv - European Journal of Physiology, 2014, 466, 1, 3

    CrossRef

  70. 70
    Akinori Nakamura, Satoshi Kuru, Akiyo Hineno, Chinatsu Kobayashi, Tomomi Kinoshita, Daigo Miyazaki, Shu-ichi Ikeda, Slowly progressing lower motor neuron disease caused by a novel duplication mutation in exon 1 of the SOD1 gene, Neurobiology of Aging, 2014, 35, 10, 2420.e7

    CrossRef

  71. 71
    Irene Faravelli, Giulietta Riboldi, Monica Nizzardo, Chiara Simone, Chiara Zanetta, Nereo Bresolin, Giacomo P. Comi, Stefania Corti, Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation, Cellular and Molecular Life Sciences, 2014, 71, 17, 3257

    CrossRef

  72. 72
    Daiyu Honda, Shinsuke Ishigaki, Yohei Iguchi, Yusuke Fujioka, Tsuyoshi Udagawa, Akio Masuda, Kinji Ohno, Masahisa Katsuno, Gen Sobue, The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons, FEBS Open Bio, 2014, 4, 1
  73. 73
    Caroline M. Tanner, Samuel M. Goldman, G. Webster Ross, Stephen J. Grate, The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk, Alzheimer's & Dementia, 2014, 10, 3, S213

    CrossRef

  74. 74
    David B. Lovejoy, Gilles J. Guillemin, The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  75. 75
    Mohammed Gebriel, Shubhangi Prabhudesai, Kai-Erik Uleberg, Eivind Larssen, Dominik Piston, Anne Hjelle Bjørnstad, Simon Geir Møller, Zebrafish brain proteomics reveals central proteins involved in neurodegeneration, Journal of Neuroscience Research, 2014, 92, 1
  76. 76
    Fabrizio Vincenzi, Carmen Corciulo, Martina Targa, Ilaria Casetta, Mauro Gentile, Enrico Granieri, Pier Andrea Borea, Patrizia Popoli, Katia Varani, A2Aadenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14, 5-6, 406

    CrossRef

  77. 77
    Lucie Ayach, Christophe Curti, Marc Montana, Pascale Pisano, Patrice Vanelle, Actualités dans le traitement étiologique de la sclérose latérale amyotrophique, Thérapie, 2013, 68, 2, 93

    CrossRef

  78. 78
    William Slotkin, Kazuko Nishikura, Adenosine-to-inosine RNA editing and human disease, Genome Medicine, 2013, 5, 11, 105

    CrossRef

  79. 79
    Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W Ostrow, David Schoenfeld, Eric A Macklin, Daniel A Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C Frank Bennett, Kathie M Bishop, Merit E Cudkowicz, An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study, The Lancet Neurology, 2013, 12, 5, 435

    CrossRef

  80. 80
    Yinan Zhang, Radhia Benmohamed, He Huang, Tian Chen, Cindy Voisine, Richard I. Morimoto, Donald R. Kirsch, Richard B. Silverman, Arylazanylpyrazolone Derivatives as Inhibitors of Mutant Superoxide Dismutase 1 Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis, Journal of Medicinal Chemistry, 2013, 56, 6, 2665

    CrossRef

  81. 81
    Angela Lanciotti, Maria Brignone, Enrico Bertini, Tamara Petrucci, Francesca Aloisi, Elena Ambrosini, Astrocytes: Emerging stars in leukodystrophy pathogenesis, Translational Neuroscience, 2013, 4, 2

    CrossRef

  82. 82
    Sharon Vinsant, Carol Mansfield, Ramon Jimenez-Moreno, Victoria Del Gaizo Moore, Masaaki Yoshikawa, Thomas G. Hampton, David Prevette, James Caress, Ronald W. Oppenheim, Carol Milligan, Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part I, background and methods, Brain and Behavior, 2013, 3, 4
  83. 83
    Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C. Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller, Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7, Progress in Neurobiology, 2013, 104, 38

    CrossRef

  84. 84
    Emanuele D’Amico, Pam Factor-Litvak, Regina M. Santella, Hiroshi Mitsumoto, Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis, Free Radical Biology and Medicine, 2013, 65, 509

    CrossRef

  85. 85
    Martin R Turner, Orla Hardiman, Michael Benatar, Benjamin R Brooks, Adriano Chio, Mamede de Carvalho, Paul G Ince, Cindy Lin, Robert G Miller, Hiroshi Mitsumoto, Garth Nicholson, John Ravits, Pamela J Shaw, Michael Swash, Kevin Talbot, Bryan J Traynor, Leonard H Van den Berg, Jan H Veldink, Steve Vucic, Matthew C Kiernan, Controversies and priorities in amyotrophic lateral sclerosis, The Lancet Neurology, 2013, 12, 3, 310

    CrossRef

  86. 86
    Inhee Choi, Elizabeth Lee, Luke P. Lee, Current nano/biotechnological approaches in amyotrophic lateral sclerosis, Biomedical Engineering Letters, 2013, 3, 4, 209

    CrossRef

  87. 87
    Samanta Oliveira Loureiro, Luana Heimfarth, Emilene B.S. Scherer, Maira J. da Cunha, Bárbara Ortiz de Lima, Helena Biasibetti, Regina Pessoa-Pureur, Angela T.S. Wyse, Cytoskeleton of cortical astrocytes as a target to proline through oxidative stress mechanisms, Experimental Cell Research, 2013, 319, 3, 89

    CrossRef

  88. 88
    Amélie O. Dumont, Emmanuel Hermans, Stéphanie Goursaud, Differential regulation of the glutamate transporter variants GLT-1a and GLT-1b in the cortex and spinal cord of transgenic rats expressing hSOD1G93A, Neurochemistry International, 2013, 63, 2, 61

    CrossRef

  89. 89
    Sonja Körner, Sebastian Böselt, Nadine Thau, Klaus Jan Rath, Reinhard Dengler, Susanne Petri, Differential Sirtuin Expression Patterns in Amyotrophic Lateral Sclerosis (ALS) Postmortem Tissue: Neuroprotective or Neurotoxic Properties of Sirtuins in ALS?, Neurodegenerative Diseases, 2013, 11, 3, 141

    CrossRef

  90. 90
    Oliver Maier, Julia Böhm, Michael Dahm, Stefan Brück, Cordian Beyer, Sonja Johann, Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration, Neurochemistry International, 2013, 62, 8, 1029

    CrossRef

  91. 91
    Tameko Kihira, Kazushi Okamoto, Sohei Yoshida, Tetuya Kondo, Keiko Iwai, Sachiko Wada, Yoshinori Kajimoto, Tomoyoshi Kondo, Yasumasa Kokubo, Shigeki Kuzuhara, Environmental Characteristics and Oxidative Stress of Inhabitants and Patients with Amyotrophic Lateral Sclerosis in a High-incidence Area on the Kii Peninsula, Japan, Internal Medicine, 2013, 52, 13, 1479

    CrossRef

  92. 92
    Mark P. Mattson, Excitation BolsTORs Motor Neurons in ALS Mice, Neuron, 2013, 80, 1, 1

    CrossRef

  93. 93
    Kunxi Zhang, Pengxiao Shi, Ting An, Qian Wang, Jingjing Wang, Zhongyao Li, Weisong Duan, Chunyan Li, Yansu Guo, Food restriction-induced autophagy modulates degradation of mutant SOD1 in an amyotrophic lateral sclerosis mouse model, Brain Research, 2013, 1519, 112

    CrossRef

  94. 94
    Yusuke Fujioka, Shinsuke Ishigaki, Akio Masuda, Yohei Iguchi, Tsuyoshi Udagawa, Hirohisa Watanabe, Masahisa Katsuno, Kinji Ohno, Gen Sobue, FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD, Scientific Reports, 2013, 3,

    CrossRef

  95. 95
    Christiaan G. J. Saris, Ewout J. N. Groen, Paul W. J. Van Vught, Michael A. van Es, Hylke M. Blauw, Jan H. Veldink, Leonard H. van den Berg, Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14, 3, 190

    CrossRef

  96. 96
    M.C. Evans, Y. Couch, N. Sibson, M.R. Turner, Inflammation and neurovascular changes in amyotrophic lateral sclerosis, Molecular and Cellular Neuroscience, 2013, 53, 34

    CrossRef

  97. 97
    Nicole L. Nichols, Genevieve Gowing, Irawan Satriotomo, Lisa J. Nashold, Erica A. Dale, Masatoshi Suzuki, Pablo Avalos, Patrick L. Mulcrone, Jacalyn McHugh, Clive N. Svendsen, Gordon S. Mitchell, Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis, American Journal of Respiratory and Critical Care Medicine, 2013, 187, 5, 535

    CrossRef

  98. 98
    Martin R. Turner, Robert Bowser, Lucie Bruijn, Luc Dupuis, Albert Ludolph, Michael McGrath, Giovanni Manfredi, Nicholas Maragakis, Robert G. Miller, Seth L. Pullman, Seward B. Rutkove, Pamela J. Shaw, Jeremy Shefner, Kenneth H. Fischbeck, Mechanisms, models and biomarkers in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14, sup1, 19

    CrossRef

  99. 99
    E. D. Koval, C. Shaner, P. Zhang, X. du Maine, K. Fischer, J. Tay, B. N. Chau, G. F. Wu, T. M. Miller, Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice, Human Molecular Genetics, 2013, 22, 20, 4127

    CrossRef

  100. 100
    Cornelia Ringer, Luisa-Sybille Büning, Martin K.H. Schäfer, Lee E. Eiden, Eberhard Weihe, Burkhard Schütz, PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis, Neurobiology of Disease, 2013, 54, 32

    CrossRef

  101. 101
    A M Brennan-Minnella, Y Shen, R A Swanson, Phosphoinositide 3-kinase couples NMDA receptors to superoxide release in excitotoxic neuronal death, Cell Death and Disease, 2013, 4, 4, e580

    CrossRef

  102. 102
    M. C. Focant, S. Goursaud, C. Boucherie, A. O. Dumont, E. Hermans, PICK1 expression in reactive astrocytes within the spinal cord of amyotrophic lateral sclerosis (ALS) rats, Neuropathology and Applied Neurobiology, 2013, 39, 3
  103. 103
    Marylène C. Focant, Emmanuel Hermans, Protein interacting with C kinase and neurological disorders, Synapse, 2013, 67, 8
  104. 104
    Joshua O. Benditt, Louis J. Boitano, Pulmonary Issues in Patients with Chronic Neuromuscular Disease, American Journal of Respiratory and Critical Care Medicine, 2013, 187, 10, 1046

    CrossRef

  105. 105
    Ray Greek, Lawrence A. Hansen, Questions regarding the predictive value of one evolved complex adaptive system for a second: Exemplified by the SOD1 mouse, Progress in Biophysics and Molecular Biology, 2013, 113, 2, 231

    CrossRef

  106. 106
    Philip McGoldrick, Peter I. Joyce, Elizabeth M.C. Fisher, Linda Greensmith, Rodent models of amyotrophic lateral sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 9, 1421

    CrossRef

  107. 107
    Ghanashyam D. Ghadge, John D. Pavlovic, Sujatha P. Koduvayur, Brian K. Kay, Raymond P. Roos, Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1, Neurobiology of Disease, 2013, 56, 74

    CrossRef

  108. 108
    Kourosh Rezania, Raymond P. Roos, Spinal Cord, Neurologic Clinics, 2013, 31, 1, 219

    CrossRef

  109. 109
    Serena Lattante, Guy A. Rouleau, Edor Kabashi, TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update, Human Mutation, 2013, 34, 6
  110. 110
    Hiroaki Suzuki, Masaaki Matsuoka, The JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death, Molecular and Cellular Biochemistry, 2013, 372, 1-2, 241

    CrossRef

  111. 111
    Yoshikatsu Kanai, Benjamin Clémençon, Alexandre Simonin, Michele Leuenberger, Martin Lochner, Martin Weisstanner, Matthias A. Hediger, The SLC1 high-affinity glutamate and neutral amino acid transporter family, Molecular Aspects of Medicine, 2013, 34, 2-3, 108

    CrossRef

  112. 112
    Kurt A. Jellinger, Metal Related Neurodegenerative Disease, 2013,

    CrossRef

  113. 113
    D.S. Folk, F. Kielar, K.J. Franz, Comprehensive Inorganic Chemistry II, 2013,

    CrossRef

  114. 114
    Zhen Huang, William Jaremko, Chi-yen Lin, Li Niu, RNA Nanotechnology and Therapeutics, 2013,

    CrossRef

  115. 115
    Lindsey R. Fischer, Yingjie Li, Seneshaw A. Asress, Dean P. Jones, Jonathan D. Glass, Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy, Experimental Neurology, 2012, 233, 1, 163

    CrossRef

  116. 116
    Mauro Cozzolino, Maria Grazia Pesaresi, Valeria Gerbino, Julian Grosskreutz, Maria Teresa Carrì, Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention, Antioxidants & Redox Signaling, 2012, 17, 9, 1277

    CrossRef

  117. 117
    S. Guareschi, E. Cova, C. Cereda, M. Ceroni, E. Donetti, D. A. Bosco, D. Trotti, P. Pasinelli, An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1, Proceedings of the National Academy of Sciences, 2012, 109, 13, 5074

    CrossRef

  118. 118
    Catherine J. E. Ingram, Michael E. Weale, Christopher A. Plaster, Karen E. Morrison, Emily F. Goodall, Hardev S. Pall, Marcus Beck, Sibylle Jablonka, Michael Sendtner, Elizabeth M. C. Fisher, Neil Bradman, Dalia Kasperavičiūtė, Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, 2012, 13, 4, 341

    CrossRef

  119. 119
    C.V. Fontanilla, X. Wei, L. Zhao, B. Johnstone, R.M. Pascuzzi, M.R. Farlow, Y. Du, Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis, Neuroscience, 2012, 205, 185

    CrossRef

  120. 120
    Fernando Cardozo-Pelaez, Richard J. Bridges, Coupling biomarkers and drug action for neurodegenerative disease therapies: Does the nose know?, Experimental Neurology, 2012, 235, 2, 508

    CrossRef

  121. 121
    Joanna Tarasiuk, Alina Kułakowska, Wiesław Drozdowski, Johannes Kornhuber, Piotr Lewczuk, CSF markers in amyotrophic lateral sclerosis, Journal of Neural Transmission, 2012, 119, 7, 747

    CrossRef

  122. 122
    Stephen Rose, Kerstin Pannek, Christopher Bell, Fusun Baumann, Nicole Hutchinson, Alan Coulthard, Pamela McCombe, Robert Henderson, Direct evidence of intra- and interhemispheric corticomotor network degeneration in amyotrophic lateral sclerosis: An automated MRI structural connectivity study, NeuroImage, 2012, 59, 3, 2661

    CrossRef

  123. 123
    Martin R. Turner, Matthew C. Kiernan, Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?, Amyotrophic Lateral Sclerosis, 2012, 13, 3, 245

    CrossRef

  124. 124
    N. Egawa, S. Kitaoka, K. Tsukita, M. Naitoh, K. Takahashi, T. Yamamoto, F. Adachi, T. Kondo, K. Okita, I. Asaka, T. Aoi, A. Watanabe, Y. Yamada, A. Morizane, J. Takahashi, T. Ayaki, H. Ito, K. Yoshikawa, S. Yamawaki, S. Suzuki, D. Watanabe, H. Hioki, T. Kaneko, K. Makioka, K. Okamoto, H. Takuma, A. Tamaoka, K. Hasegawa, T. Nonaka, M. Hasegawa, A. Kawata, M. Yoshida, T. Nakahata, R. Takahashi, M. C. N. Marchetto, F. H. Gage, S. Yamanaka, H. Inoue, Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells, Science Translational Medicine, 2012, 4, 145, 145ra104

    CrossRef

  125. 125
    Caterina Bendotti, Marianna Marino, Cristina Cheroni, Elena Fontana, Valeria Crippa, Angelo Poletti, Silvia De Biasi, Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response, Progress in Neurobiology, 2012, 97, 2, 101

    CrossRef

  126. 126
    William M. Johnson, Amy L. Wilson-Delfosse, John. J. Mieyal, Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases, Nutrients, 2012, 4, 12, 1399

    CrossRef

  127. 127
    M. Baarine, P. Andréoletti, A. Athias, T. Nury, A. Zarrouk, K. Ragot, A. Vejux, J.-M. Riedinger, Z. Kattan, G. Bessede, D. Trompier, S. Savary, M. Cherkaoui-Malki, G. Lizard, Evidence of oxidative stress in very long chain fatty acid – Treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins, Neuroscience, 2012, 213, 1

    CrossRef

  128. 128
    Thais Federici, Nicholas M. Boulis, Gene therapy for amyotrophic lateral sclerosis, Neurobiology of Disease, 2012, 48, 2, 236

    CrossRef

  129. 129
    Chien-Liang Glenn Lin, Qiongman Kong, Gregory D Cuny, Marcie A Glicksman, Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases, Future Medicinal Chemistry, 2012, 4, 13, 1689

    CrossRef

  130. 130
    Christiane Marinc, Harald Prüss, Christian Derst, Rüdiger W. Veh, Immunocytochemical Localization of TASK-3 Channels in Rat Motor Neurons, Cellular and Molecular Neurobiology, 2012, 32, 2, 309

    CrossRef

  131. 131
    Maria Carolina O. Rodrigues, Júlio C. Voltarelli, Paul R. Sanberg, Cesario V. Borlongan, Svitlana Garbuzova-Davis, Immunological Aspects in Amyotrophic Lateral Sclerosis, Translational Stroke Research, 2012, 3, 3, 331

    CrossRef

  132. 132
    Svitlana Garbuzova-Davis, Diana G. Hernandez-Ontiveros, Maria C.O. Rodrigues, Edward Haller, Aric Frisina-Deyo, Santhia Mirtyl, Sebastian Sallot, Samuel Saporta, Cesario V. Borlongan, Paul R. Sanberg, Impaired blood–brain/spinal cord barrier in ALS patients, Brain Research, 2012, 1469, 114

    CrossRef

  133. 133
    Christian Lunetta, Massimo Serafini, Alessandro Prelle, Paolo Magni, Elena Dozio, Massimiliano Ruscica, Jenny Sassone, Clarissa Colciago, Maurizio Moggio, Massimo Corbo, Vincenzo Silani, Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients, Muscle & Nerve, 2012, 45, 2
  134. 134
    Matthew C. Evans, Michel Modo, Kevin Talbot, Niki Sibson, Martin R. Turner, Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, 2012, 13, 3, 288

    CrossRef

  135. 135
    Y. D. Teng, S. C. Benn, S. N. Kalkanis, J. M. Shefner, R. C. Onario, B. Cheng, M. B. Lachyankar, M. Marconi, J. Li, D. Yu, I. Han, N. J. Maragakis, J. Llado, K. Erkmen, D. E. Redmond, R. L. Sidman, S. Przedborski, J. D. Rothstein, R. H. Brown, E. Y. Snyder, Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis, Science Translational Medicine, 2012, 4, 165, 165ra164

    CrossRef

  136. 136
    Martin R Turner, Federica Agosta, Peter Bede, Varan Govind, Dorothée Lulé, Esther Verstraete, Neuroimaging in amyotrophic lateral sclerosis, Biomarkers in Medicine, 2012, 6, 3, 319

    CrossRef

  137. 137
    M.D. Scofield, L. Korutla, T.G. Jackson, P.W. Kalivas, S.A. Mackler, Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis, Neuroscience, 2012, 227, 44

    CrossRef

  138. 138
    Kikyo Lee, Hiroaki Suzuki, Sadakazu Aiso, Masaaki Matsuoka, Overexpression of TDP-43 causes partially p53-dependent G2/M arrest and p53-independent cell death in HeLa cells, Neuroscience Letters, 2012, 506, 2, 271

    CrossRef

  139. 139
    Rochelle Wei, Arunabh Bhattacharya, Naveen Chintalaramulu, Amanda L. Jernigan, Yuhong Liu, Holly Van Remmen, Asish R. Chaudhuri, Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS, Biochemical and Biophysical Research Communications, 2012, 417, 4, 1275

    CrossRef

  140. 140
    M Nawa, E Kage-Nakadai, S Aiso, K Okamoto, S Mitani, M Matsuoka, Reduced expression of BTBD10, an Akt activator, leads to motor neuron death, Cell Death and Differentiation, 2012, 19, 8, 1398

    CrossRef

  141. 141
    C.Y. Lin, C.M. Pfluger, R.D. Henderson, P.A. McCombe, Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis, Journal of Neuroimmunology, 2012, 249, 1-2, 93

    CrossRef

  142. 142
    Fadia Ibrahim, Tadashi Nakaya, Zissimos Mourelatos, RNA Dysregulation in Diseases of Motor Neurons, Annual Review of Pathology: Mechanisms of Disease, 2012, 7, 1, 323

    CrossRef

  143. 143
    Keith A. Hanson, Sang Hwa Kim, Randal S. Tibbetts, RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond, Wiley Interdisciplinary Reviews: RNA, 2012, 3, 2
  144. 144
    William Tsao, Yun Ha Jeong, Sophie Lin, Jonathan Ling, Donald L. Price, Po-Min Chiang, Philip C. Wong, Rodent models of TDP-43: Recent advances, Brain Research, 2012, 1462, 26

    CrossRef

  145. 145
    Lijun Wang, Peter Pytel, M. Laura Feltri, Lawrence Wrabetz, Raymond P. Roos, Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice, Neurobiology of Disease, 2012, 48, 1, 52

    CrossRef

  146. 146
    H Z Yin, A Nalbandian, C-I Hsu, S Li, K J Llewellyn, T Mozaffar, V E Kimonis, J H Weiss, Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice, Cell Death and Disease, 2012, 3, 8, e374

    CrossRef

  147. 147
    Wendy L. Imlach, Erin S. Beck, Ben Jiwon Choi, Francesco Lotti, Livio Pellizzoni, Brian D. McCabe, SMN Is Required for Sensory-Motor Circuit Function in Drosophila, Cell, 2012, 151, 2, 427

    CrossRef

  148. 148
    S. W. de Jong, M. H. B. Huisman, N. A. Sutedja, A. J. van der Kooi, M. de Visser, H. J. Schelhaas, K. Fischer, J. H. Veldink, L. H. van den Berg, Smoking, Alcohol Consumption, and the Risk of Amyotrophic Lateral Sclerosis: A Population-based Study, American Journal of Epidemiology, 2012, 176, 3, 233

    CrossRef

  149. 149
    Randy Peterson, John Turnbull, Sonic Hedgehog is Cytoprotective against Oxidative Challenge in a Cellular Model of Amyotrophic Lateral Sclerosis, Journal of Molecular Neuroscience, 2012, 47, 1, 31

    CrossRef

  150. 150
    Paul C. Trippier, Radhia Benmohamed, Donald R. Kirsch, Richard B. Silverman, Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 21, 6647

    CrossRef

  151. 151
    Hiroaki Suzuki, Masaaki Matsuoka, TDP-43 toxicity is mediated by the unfolded protein response-unrelated induction of C/EBP homologous protein expression, Journal of Neuroscience Research, 2012, 90, 3
  152. 152
    Francieli J. Rockenbach, Marion Deon, Daiane P. Marchese, Vanusa Manfredini, Caroline Mescka, Graziela S. Ribas, Clarissa T. Habekost, Claudio G. Castro, Laura B. Jardim, Carmen R. Vargas, The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy, Molecular Genetics and Metabolism, 2012, 106, 2, 231

    CrossRef

  153. 153
    S.T. Ngo, F. Baumann, P.G. Ridall, A.N. Pettitt, R.D. Henderson, M.C. Bellingham, P.A. McCombe, The relationship between Bayesian motor unit number estimation and histological measurements of motor neurons in wild-type and SOD1G93A mice, Clinical Neurophysiology, 2012, 123, 10, 2080

    CrossRef

  154. 154
    T. Prell, J. Lautenschläger, O. W. Witte, M. T. Carri, J. Grosskreutz, The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis, European Journal of Neuroscience, 2012, 35, 5
  155. 155
    Jonathan Riley, Carl V Hurtig, Nicholas Boulis, Translating cellular therapies from bench to bedside for amyotrophic lateral sclerosis, Personalized Medicine, 2012, 9, 6, 645

    CrossRef

  156. 156
    F. Baumann, R.D. Henderson, P.G. Ridall, A.N. Pettitt, Pamela A. McCombe, Use of Bayesian MUNE to show differing rate of loss of motor units in subgroups of ALS, Clinical Neurophysiology, 2012, 123, 12, 2446

    CrossRef

  157. You have free access to this content157
    Sophie R. Thomson, Thomas M. Wishart, Rickie Patani, Siddharthan Chandran, Thomas H. Gillingwater, Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?, Journal of Anatomy, 2012, 220, 2
  158. 158
    Kevin D. Sarge, Ok-Kyong Park-Sarge, WITHDRAWN: Protein sumoylation and human diseases, Biochimie, 2012,

    CrossRef

  159. 159
    Rachel L. Redler, Nikolay V. Dokholyan, Molecular Biology of Neurodegenerative Diseases, 2012,

    CrossRef

  160. 160
    Maria Carolina O. Rodrigues, Diana G. Hernandez-Ontiveros, Michael K. Louis, Alison E. Willing, Cesario V. Borlongan, Paul R. Sanberg, Júlio C. Voltarelli, Svitlana Garbuzova-Davis, New Perspectives of Central Nervous System Injury and Neuroprotection, 2012,

    CrossRef

  161. 161
    Jean Cambier, Maurice Masson, Catherine Masson, † Henri Dehen, Neurologie, 2012,

    CrossRef

  162. 162
    Christina M. Lill, Rudolph E. Tanzi, Lars Bertram, Basic Neurochemistry, 2012,

    CrossRef

  163. 163
    Noriyuki Shibata, Yoichiro Kato, Yuri Inose, Atsuko Hiroi, Tomoko Yamamoto, Shunichi Morikawa, Makoto Sawada, Makio Kobayashi, 4-hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A2 in cultured Ra2 microglial cells via MAPK pathways, Neuropathology, 2011, 31, 2
  164. 164
    Cyntia Tremblay, Isabelle St-Amour, Julie Schneider, David A. Bennett, Frédéric Calon, Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease, Journal of Neuropathology and Experimental Neurology, 2011, 70, 9, 788

    CrossRef

  165. 165
    Izzet Enunlu, Mehmet Ozansoy, Ayse Nazlı Basak, Alfa-class prefoldin protein UXT is a novel interacting partner of Amyotrophic Lateral Sclerosis 2 (Als2) protein, Biochemical and Biophysical Research Communications, 2011, 413, 3, 471

    CrossRef

  166. 166
    Cinzia Volonté, Savina Apolloni, Maria Teresa Carrì, Nadia D'Ambrosi, ALS: Focus on purinergic signalling, Pharmacology & Therapeutics, 2011, 132, 1, 111

    CrossRef

  167. 167
    K. A. Quinlan, J. E. Schuster, R. Fu, T. Siddique, C. J. Heckman, Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis, The Journal of Physiology, 2011, 589, 9
  168. 168
    Paul H. Gordon, Amyotrophic Lateral Sclerosis, CNS Drugs, 2011, 25, 1, 1

    CrossRef

  169. 169
    Hiroaki Suzuki, Masaaki Matsuoka, Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity, Journal of Neurochemistry, 2011, 119, 5
  170. 170
    Svitlana Garbuzova-Davis, Maria C.O. Rodrigues, Diana G. Hernandez-Ontiveros, Michael K. Louis, Alison E. Willing, Cesario V. Borlongan, Paul R. Sanberg, Amyotrophic lateral sclerosis: A neurovascular disease, Brain Research, 2011, 1398, 113

    CrossRef

  171. 171
    Jing Hua Jiang, Eun Jin Yang, Myung Gi Baek, Seon Hwy Kim, Sang Min Lee, Sun-Mi Choi, Anti-Inflammatory Effects of Electroacupuncture in the Respiratory System of a Symptomatic Amyotrophic Lateral Sclerosis Animal Model, Neurodegenerative Diseases, 2011, 8, 6, 504

    CrossRef

  172. 172
    L. Wang, D. H. Gutmann, R. P. Roos, Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice, Human Molecular Genetics, 2011, 20, 2, 286

    CrossRef

  173. 173
    Ciro Iaccarino, Maria Elena Mura, Sonia Esposito, Franco Carta, Giovanna Sanna, Franco Turrini, Maria Teresa Carrì, Claudia Crosio, Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis, Neurobiology of Disease, 2011, 43, 3, 642

    CrossRef

  174. 174
    Alexandre Henriques, Claudia Pitzer, Tanjew Dittgen, Matthias Klugmann, Luc Dupuis, Armin Schneider, CNS-targeted Viral Delivery of G-CSF in an Animal Model for ALS: Improved Efficacy and Preservation of the Neuromuscular Unit, Molecular Therapy, 2011, 19, 2, 284

    CrossRef

  175. 175
    Jeban Ganesalingam, Jiyan An, Christopher E. Shaw, Gerry Shaw, David Lacomis, Robert Bowser, Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS, Journal of Neurochemistry, 2011, 117, 3
  176. 176
    Giovanni De Marco, Elisa Lupino, Andrea Calvo, Cristina Moglia, Barbara Buccinnà, Silvia Grifoni, Cristina Ramondetti, Annarosa Lomartire, Maria Teresa Rinaudo, Marco Piccinini, Maria Teresa Giordana, Adriano Chiò, Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations, Acta Neuropathologica, 2011, 121, 5, 611

    CrossRef

  177. 177
    Ali Aamer Habib, Hiroshi Mitsumoto, Emerging drugs for amyotrophic lateral sclerosis, Expert Opinion on Emerging Drugs, 2011, 16, 3, 537

    CrossRef

  178. 178
    Lauren E. Parlett, Joseph D. Bowman, Edwin van Wijngaarden, Evaluation of Occupational Exposure to Magnetic Fields and Motor Neuron Disease Mortality in a Population-Based Cohort, Journal of Occupational and Environmental Medicine, 2011, 53, 12, 1447

    CrossRef

  179. 179
    Eike D. Schomburg, Heinz Steffens, Jana Zschüntzsch, Payam Dibaj, Bernhard U. Keller, Fatigability of spinal reflex transmission in a mouse model (SOD1G93A) of amyotrophic lateral sclerosis, Muscle & Nerve, 2011, 43, 2
  180. 180
    Giuseppina D'Alessandro, Eleonora Calcagno, Silvia Tartari, Milena Rizzardini, Roberto William Invernizzi, Lavinia Cantoni, Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism, Neurobiology of Disease, 2011, 43, 2, 346

    CrossRef

  181. 181
    Yun Li, Rita Sattler, Eun Ju Yang, Alice Nunes, Yoko Ayukawa, Sadia Akhtar, Grace Ji, Ping-Wu Zhang, Jeffrey D. Rothstein, Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression, Neuropharmacology, 2011, 60, 7-8, 1168

    CrossRef

  182. 182
    Paul H. Gordon, Vincent Meininger, How can we improve clinical trials in amyotrophic lateral sclerosis?, Nature Reviews Neurology, 2011, 7, 11, 650

    CrossRef

  183. 183
    Radhia Benmohamed, Anthony C. Arvanites, Jinho Kim, Robert J. Ferrante, Richard B. Silverman, Richard I. Morimoto, Donald R. Kirsch, Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, 2011, 12, 2, 87

    CrossRef

  184. 184
    Yonghwang Ha, Hyunjeong Liew, Hyun Young Park, Kibong Kim, Yoo-Hun Suh, David G. Churchill, Interplay of salicylaldehyde, lysine, and M2+ ions on α-synuclein aggregation: Cancellation of aggregation effects and determination of salicylaldehyde neurotoxicity, Neuroscience Research, 2011, 71, 2, 168

    CrossRef

  185. 185
    Renshi Xu, Chengsi Wu, Xiong Zhang, Qiong Zhang, Yunzhu Yang, Juan Yi, Rongwei Yang, Yuhui Tao, Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS, Brain Research, 2011, 1372, 133

    CrossRef

  186. 186
    Kai Y Soo, Manal Farg, Julie D. Atkin, Molecular Motor Proteins and Amyotrophic Lateral Sclerosis, International Journal of Molecular Sciences, 2011, 12, 12, 9057

    CrossRef

  187. 187
    Martin R Turner, MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?, Biomarkers in Medicine, 2011, 5, 1, 79

    CrossRef

  188. 188
    Silvia C. Lenzken, Valentina Romeo, Francesca Zolezzi, Francesca Cordero, Giuseppe Lamorte, Davide Bonanno, Donatella Biancolini, Mauro Cozzolino, Maria Grazia Pesaresi, Alessia Maracchioni, Remo Sanges, Tilmann Achsel, Maria Teresa Carrì, Raffaele A. Calogero, Silvia M.L. Barabino, Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration, Human Mutation, 2011, 32, 2
  189. 189
    Bernardo Moreno-López, Carmen R. Sunico, David González-Forero, NO Orchestrates the Loss of Synaptic Boutons from Adult “Sick” Motoneurons: Modeling a Molecular Mechanism, Molecular Neurobiology, 2011, 43, 1, 41

    CrossRef

  190. 190
    Min-Sun Kim, Hee Ra Park, Hae Young Chung, Hyung Sik Kim, Byung Pal Yu, Hee-Sun Yang, Jaewon Lee, Organic solvent metabolite, 1,2-diacetylbenzene, impairs neural progenitor cells and hippocampal neurogenesis, Chemico-Biological Interactions, 2011, 194, 2-3, 139

    CrossRef

  191. 191
    Susanna Amadio, Savina Apolloni, Nadia D’Ambrosi, Cinzia Volonté, Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis, Journal of Neurochemistry, 2011, 116, 5
  192. 192
    Guoyao Xia, Radhia Benmohamed, Jinho Kim, Anthony C. Arvanites, Richard I. Morimoto, Robert J. Ferrante, Donald R. Kirsch, Richard B. Silverman, Pyrimidine-2,4,6-trione Derivatives and Their Inhibition of Mutant SOD1-Dependent Protein Aggregation. Toward a Treatment for Amyotrophic Lateral Sclerosis, Journal of Medicinal Chemistry, 2011, 54, 7, 2409

    CrossRef

  193. 193
    Carmen R. Sunico, Germán Domínguez, José Manuel García-Verdugo, Rosario Osta, Fernando Montero, Bernardo Moreno-López, Reduction in the Motoneuron Inhibitory/Excitatory Synaptic Ratio in an Early-Symptomatic Mouse Model of Amyotrophic Lateral Sclerosis, Brain Pathology, 2011, 21, 1
  194. 194
    Rebecca Traub, Hiroshi Mitsumoto, Lewis P. Rowland, Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010, Current Neurology and Neuroscience Reports, 2011, 11, 1, 67

    CrossRef

  195. 195
    Laura Texidó, Sara Hernández, Mireia Martín-Satué, Mònica Povedano, Anna Casanovas, Josep Esquerda, Jordi Marsal, Carles Solsona, Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors “in vitro”, Neurochemistry International, 2011, 59, 6, 954

    CrossRef

  196. 196
    Adam K. Walker, Julie D. Atkin, Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis, IUBMB Life, 2011, 63, 9
  197. 197
    Tohru Fukai, Masuko Ushio-Fukai, Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases, Antioxidants & Redox Signaling, 2011, 15, 6, 1583

    CrossRef

  198. 198
    Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, József I. Engelhardt, László Siklós, Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically, Amyotrophic Lateral Sclerosis, 2011, 12, 5, 340

    CrossRef

  199. 199
    Massimiliano Filosto, Mauro Scarpelli, Maria Sofia Cotelli, Valentina Vielmi, Alice Todeschini, Valeria Gregorelli, Paola Tonin, Giuliano Tomelleri, Alessandro Padovani, The role of mitochondria in neurodegenerative diseases, Journal of Neurology, 2011, 258, 10, 1763

    CrossRef

  200. 200
    E. Canu, F. Agosta, N. Riva, S. Sala, A. Prelle, D. Caputo, M. Perini, G. Comi, M. Filippi, The Topography of Brain Microstructural Damage in Amyotrophic Lateral Sclerosis Assessed Using Diffusion Tensor MR Imaging, American Journal of Neuroradiology, 2011, 32, 7, 1307

    CrossRef

  201. 201
    L. Wang, B. Popko, R. P. Roos, The unfolded protein response in familial amyotrophic lateral sclerosis, Human Molecular Genetics, 2011, 20, 5, 1008

    CrossRef

  202. 202
    Diana García del Barco, Héctor Pérez-Saad, Valia Rodríguez, Javier Marín, Viviana Falcón, Jorge Martín, Danay Cibrian, Jorge Berlanga, Therapeutic Effect of the Combined Use of Growth Hormone Releasing Peptide-6 and Epidermal Growth Factor in an Axonopathy Model, Neurotoxicity Research, 2011, 19, 1, 195

    CrossRef

  203. 203
    Nicholas M. Boulis, Thais Federici, Jonathan D. Glass, J. Simon Lunn, Stacey A. Sakowski, Eva L. Feldman, Translational stem cell therapy for amyotrophic lateral sclerosis, Nature Reviews Neurology, 2011, 8, 3, 172

    CrossRef

  204. 204
    Juan S. Bonifacino, Aitor Hierro, Transport according to GARP: receiving retrograde cargo at the trans-Golgi network, Trends in Cell Biology, 2011, 21, 3, 159

    CrossRef

  205. 205
    Gray's Clinical Neuroanatomy: The Anatomic Basis for Clinical Neuroscience, 2011,

    CrossRef

  206. 206
    Kevin D. Sarge, Ok-Kyong Park-Sarge, 2011,

    CrossRef

  207. 207
    Robert M. Pascuzzi, Jeremy Shefner, Amy S. Chappell, John S. Bjerke, Roy Tamura, Vinay Chaudhry, Lora Clawson, Lisa Haas, Jeffrey D. Rothstein, A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis, 2010, 11, 3, 266

    CrossRef

  208. 208
    Todd D. Levine, Robert Bowser, Nicole Hank, David Saperstein, A pilot trial of memantine and riluzole in ALS: Correlation to CSF biomarkers, Amyotrophic Lateral Sclerosis, 2010, 11, 6, 514

    CrossRef

  209. 209
    Karen Anthony, Jean-Marc Gallo, Aberrant RNA processing events in neurological disorders, Brain Research, 2010, 1338, 67

    CrossRef

  210. 210
    Bo Su, Xinglong Wang, Ling Zheng, George Perry, Mark A. Smith, Xiongwei Zhu, Abnormal mitochondrial dynamics and neurodegenerative diseases, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 135

    CrossRef

  211. 211
    Noriyuki Shibata, Tomoko Yamamoto, Atsuko Hiroi, Yoko Omi, Yoichiro Kato, Makio Kobayashi, Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis, Neuropathology, 2010, 30, 4
  212. 212
    Martin R Turner, Michel Modo, Advances in the application of MRI to amyotrophic lateral sclerosis, Expert Opinion on Medical Diagnostics, 2010, 4, 6, 483

    CrossRef

  213. 213
    Q. Li, C. Vande Velde, A. Israelson, J. Xie, A. O. Bailey, M.-Q. Dong, S.-J. Chun, T. Roy, L. Winer, J. R. Yates, R. A. Capaldi, D. W. Cleveland, T. M. Miller, ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import, Proceedings of the National Academy of Sciences, 2010, 107, 49, 21146

    CrossRef

  214. 214
    Lewis P. Rowland, Ameliorating Amyotrophic Lateral Sclerosis, New England Journal of Medicine, 2010, 362, 10, 953

    CrossRef

  215. 215
    Satoshi Yamashita, Akie Migita, Kenyu Hayashi, Tomoo Hirahara, En Kimura, Yasushi Maeda, Teruyuki Hirano, Makoto Uchino, Amyotrophic lateral sclerosis in a patient with Kartagener syndrome, Amyotrophic Lateral Sclerosis, 2010, 11, 4, 402

    CrossRef

  216. 216
    Aaron Kerman, Hsueh-Ning Liu, Sidney Croul, Juan Bilbao, Ekaterina Rogaeva, Lorne Zinman, Janice Robertson, Avijit Chakrabartty, Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form, Acta Neuropathologica, 2010, 119, 3, 335

    CrossRef

  217. 217
    F. Fang, L. C. Kwee, K. D. Allen, D. M. Umbach, W. Ye, M. Watson, J. Keller, E. Z. Oddone, D. P. Sandler, S. Schmidt, F. Kamel, Association Between Blood Lead and the Risk of Amyotrophic Lateral Sclerosis, American Journal of Epidemiology, 2010, 171, 10, 1126

    CrossRef

  218. 218
    Malcolm Ward, Emma Louise Schofield, Biomarkers for brain disorders, Therapy, 2010, 7, 4, 321

    CrossRef

  219. 219
    J. W. M. van der Meer, A. Simon, Blocking IL-1  to slow down progression of ALS?, Proceedings of the National Academy of Sciences, 2010, 107, 29, 12741

    CrossRef

  220. 220
    R. Lee Mosley, Howard E. Gendelman, Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders, Experimental Neurology, 2010, 222, 1, 1

    CrossRef

  221. 221
    Johannes Berger, Aurora Pujol, Patrick Aubourg, Sonja Forss-Petter, Current and Future Pharmacological Treatment Strategies in X-Linked Adrenoleukodystrophy, Brain Pathology, 2010, 20, 4
  222. 222
    Satoshi Yamashita, Akira Mori, En Kimura, Shuji Mita, Yasushi Maeda, Teruyuki Hirano, Makoto Uchino, DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity, Journal of Neurochemistry, 2010, 113, 4
  223. 223
    Heejaung Kim, Hyun Young Kim, Mi Ran Choi, Sejin Hwang, Ki-Hoan Nam, Hyoung-Chin Kim, Jin Soo Han, Kyung Suk Kim, Hyun Soo Yoon, Seung H. Kim, Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice, Neuroscience Letters, 2010, 468, 3, 190

    CrossRef

  224. 224
    Andrea Fuchs, Cornelia Ringer, Andras Bilkei-Gorzo, Eberhard Weihe, Jochen Roeper, Burkhard Schütz, Downregulation of the Potassium Chloride Cotransporter KCC2 in Vulnerable Motoneurons in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis, Journal of Neuropathology and Experimental Neurology, 2010, 69, 10, 1057

    CrossRef

  225. You have free access to this content225
    Thomas E. Lloyd, J. Paul Taylor, Flightless flies: Drosophila models of neuromuscular disease, Annals of the New York Academy of Sciences, 2010, 1184, 1
  226. 226
    M. Gasperi, A. E. Castellano, Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases, Journal of Endocrinological Investigation, 2010, 33, 8, 587

    CrossRef

  227. 227
    Martin R. Turner, Julie Abisgold, David G.R. Yeates, Kevin Talbot, Michael J. Goldacre, Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS, Journal of the Neurological Sciences, 2010, 288, 1-2, 45

    CrossRef

  228. 228
    Melinda Paizs, József I. Engelhardt, Zója Katarova, László Siklós, Hypoglossal motor neurons display a reduced calcium increase after axotomy in mice with upregulated parvalbumin, Journal of Comparative Neurology, 2010, 518, 11
  229. 229
    Hibiki Kawamata, Giovanni Manfredi, Import, Maturation, and Function of SOD1 and Its Copper Chaperone CCS in the Mitochondrial Intermembrane Space, Antioxidants & Redox Signaling, 2010, 13, 9, 1375

    CrossRef

  230. 230
    L. C. Kudo, L. Parfenova, N. Vi, K. Lau, J. Pomakian, P. Valdmanis, G. A. Rouleau, H. V. Vinters, M. Wiedau-Pazos, S. L. Karsten, Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis, Human Molecular Genetics, 2010, 19, 16, 3233

    CrossRef

  231. 231
    R. W. Orrell, Motor neuron disease: systematic reviews of treatment for ALS and SMA, British Medical Bulletin, 2010, 93, 1, 145

    CrossRef

  232. 232
    Beatrice Nefussy, Vivian E. Drory, Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies, EPMA Journal, 2010, 1, 2, 329

    CrossRef

  233. 233
    Youfeng Yang, Sung Min Han, Michael A. Miller, MSP hormonal control of the oocyte MAP kinase cascade and reactive oxygen species signaling, Developmental Biology, 2010, 342, 1, 96

    CrossRef

  234. 234
    F. Meissner, K. Molawi, A. Zychlinsky, Mutant superoxide dismutase 1-induced IL-1  accelerates ALS pathogenesis, Proceedings of the National Academy of Sciences, 2010, 107, 29, 13046

    CrossRef

  235. 235
    Lindsey R. Fischer, Jonathan D. Glass, Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures, Acta Neuropathologica, 2010, 119, 2, 249

    CrossRef

  236. 236
    Koichi Okamoto, Yukio Fujita, Yuji Mizuno, Pathology of protein synthesis and degradation systems in ALS, Neuropathology, 2010, 30, 2
  237. 237
    A. K. Walker, M. A. Farg, C. R. Bye, C. A. McLean, M. K. Horne, J. D. Atkin, Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis, Brain, 2010, 133, 1, 105

    CrossRef

  238. 238
    L. M. Murray, K. Talbot, T. H. Gillingwater, Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy, Neuropathology and Applied Neurobiology, 2010, 36, 2
  239. 239
    L. M. Murray, K. Talbot, T. H. Gillingwater, Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy, Neuropathology and Applied Neurobiology, 2010, 36, 2
  240. 240
    T. F. Gendron, K. A. Josephs, L. Petrucelli, Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration, Neuropathology and Applied Neurobiology, 2010, 36, 2
  241. 241
    T. F. Gendron, K. A. Josephs, L. Petrucelli, Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration, Neuropathology and Applied Neurobiology, 2010, 36, 2
  242. 242
    Peethambaran Arun, John R. Moffett, Aryan M.A. Namboodiri, Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells, Brain Research, 2010, 1334, 25

    CrossRef

  243. 243
    Stefania Battistini, Claudia Ricci, Enrico Maria Lotti, Michele Benigni, Stella Gagliardi, Riccardo Zucco, Massimo Bondavalli, Norina Marcello, Mauro Ceroni, Cristina Cereda, Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene, Journal of the Neurological Sciences, 2010, 293, 1-2, 112

    CrossRef

  244. 244
    Daniel B. Drachman, Robert N. Adams, Uma Balasubramanian, Yang Lu, Strategy for Treating Motor Neuron Diseases Using a Fusion Protein of Botulinum Toxin Binding Domain and Streptavidin for Viral Vector Access: Work in Progress, Toxins, 2010, 2, 12, 2872

    CrossRef

  245. 245
    Silvia Rossi, Giorgio Bernardi, Diego Centonze, The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis, Experimental Neurology, 2010, 224, 1, 92

    CrossRef

  246. 246
    M. T. Pellecchia, R. Pivonello, M. R. Monsurrò, F. Trojsi, K. Longo, G. Piccirillo, C. Pivonello, M. Rocco, C. Di Somma, A. Colao, G. Tedeschi, P. Barone, The GH–IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features, European Journal of Neurology, 2010, 17, 5
  247. 247
    Yiquan Chen, Roger Stankovic, Karen M. Cullen, Vincent Meininger, Brett Garner, Sarah Coggan, Ross Grant, Bruce J. Brew, Gilles J. Guillemin, The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis, Neurotoxicity Research, 2010, 18, 2, 132

    CrossRef

  248. 248
    Antonello D’Arrigo, Davide Colavito, Emiliano Peña-Altamira, Michele Fabris, Mauro Dam, Antonio Contestabile, Alberta Leon, Transcriptional Profiling in the Lumbar Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis: A Role for Wild-Type Superoxide Dismutase 1 in Sporadic Disease?, Journal of Molecular Neuroscience, 2010, 41, 3, 404

    CrossRef

  249. 249
    Marie Csete, Translational prospects for human induced pluripotent stem cells, Regenerative Medicine, 2010, 5, 4, 509

    CrossRef

  250. 250
    Daniel J. Amante, Jinho Kim, Samantha T. Carreiro, Andrew C. Cooper, Steven W. Jones, Ting Li, Jennifer P. Moody, Christina K. Edgerly, Olivia L. Bordiuk, Kerry Cormier, Karen Smith, Robert J. Ferrante, James Rusche, Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice, Amyotrophic Lateral Sclerosis, 2010, 11, 6, 520

    CrossRef

  251. 251
    S. Fourcade, M. Ruiz, C. Guilera, E. Hahnen, L. Brichta, A. Naudi, M. Portero-Otin, G. Dacremont, N. Cartier, R. Wanders, S. Kemp, J. L. Mandel, B. Wirth, R. Pamplona, P. Aubourg, A. Pujol, Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy, Human Molecular Genetics, 2010, 19, 10, 2005

    CrossRef

  252. 252
    Edwin Trevathan, Chronic Disease Epidemiology and Control, 2010,

    CrossRef

  253. 253
    Ewoud R.E. Schmidt, R. Jeroen Pasterkamp, Leonard H. van den Berg, Axon guidance proteins: Novel therapeutic targets for ALS?, Progress in Neurobiology, 2009, 88, 4, 286

    CrossRef

  254. 254
    James C. Vickers, Anna E. King, Adele Woodhouse, Matthew T. Kirkcaldie, Jerome A. Staal, Graeme H. McCormack, Catherine A. Blizzard, Ruth E.J. Musgrove, Stanislaw Mitew, Yao Liu, Jyoti A. Chuckowree, Olivier Bibari, Tracey C. Dickson, Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system, Brain Research Bulletin, 2009, 80, 4-5, 217

    CrossRef

  255. 255
    Haruka Wada, Takuwa Yasuda, Ikuo Miura, Kazuhiko Watabe, Chika Sawa, Hajime Kamijuku, Satoshi Kojo, Masaru Taniguchi, Ichizo Nishino, Shigeharu Wakana, Hisahiro Yoshida, Ken-ichiro Seino, Establishment of an Improved Mouse Model for Infantile Neuroaxonal Dystrophy That Shows Early Disease Onset and Bears a Point Mutation in Pla2g6, The American Journal of Pathology, 2009, 175, 6, 2257

    CrossRef

  256. 256
    Fumiaki Tanaka, Masahiro Waza, Masahiko Yamamoto, Gen Sobue, Exploration of pathogenesis and therapy development for ALS employing sporadic disease model, Rinsho Shinkeigaku, 2009, 49, 11, 811

    CrossRef

  257. 257
    Patrick A. Dion, Hussein Daoud, Guy A. Rouleau, Genetics of motor neuron disorders: new insights into pathogenic mechanisms, Nature Reviews Genetics, 2009, 10, 11, 769

    CrossRef

  258. 258
    Ari Nowacek, Lisa M Kosloski, Howard E Gendelman, Neurodegenerative disorders and nanoformulated drug development, Nanomedicine, 2009, 4, 5, 541

    CrossRef

  259. 259
    Päivi Liesi, Neuroprotective effects of laminin and its KDI domain, Future Neurology, 2009, 4, 5, 561

    CrossRef

  260. 260
    Mary Kay Floeter, Reversa Mills, Progression in primary lateral sclerosis: A prospective analysis, Amyotrophic Lateral Sclerosis, 2009, 10, 5-6, 339

    CrossRef

  261. 261
    Philip Van Damme, Wim Robberecht, Recent advances in motor neuron disease, Current Opinion in Neurology, 2009, 22, 5, 486

    CrossRef

  262. 262
    Kurt A. Jellinger, Recent advances in our understanding of neurodegeneration, Journal of Neural Transmission, 2009, 116, 9, 1111

    CrossRef

  263. 263
    Letizia Mazzini, Alessandro Vercelli, Ivana Ferrero, Katia Mareschi, Marina Boido, Serena Servo, Gaia Donata Oggioni, Lucia Testa, Francesco Monaco, Franca Fagioli, Stem cells in amyotrophic lateral sclerosis: state of the art, Expert Opinion on Biological Therapy, 2009, 9, 10, 1245

    CrossRef

  264. 264
    Walter G. Bradley, Updates on amyotrophic lateral sclerosis: Improving patient care, Annals of Neurology, 2009, 65, S1
  265. 265
    Bryan J Traynor, Andrew B Singleton, What's the FUS!, The Lancet Neurology, 2009, 8, 5, 418

    CrossRef

  266. 266
    Marjatta Son, Jeffrey L. Elliott, ALS and the Copper Chaperone CCS,
  267. You have free access to this content267
    Orla Hardiman, Amyotrophic Lateral Sclerosis, eLS,
  268. 268
    Amy Chen, Hiroshi Mitsumoto, Amyotrophic Lateral Sclerosis,
  269. 269
    Britt Gabrielsson, Niklas Andersson, Ingrid Undeland, Influence of fish consumption and some of its individual constituents on oxidative stress in cells, animals, and humans,
  270. 270
    C.J. Heckman, Roger M. Enoka, Motor Unit, Comprehensive Physiology,